Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel.
Vivaldi C, Crucitta S, Catanese S, Cucchiara F, Arrigoni E, Pecora I, Rofi E, Fornaro L, Salani F, Massa V, Vasile E, Morganti R, Danesi R, Del Re M. Vivaldi C, et al. Among authors: cucchiara f. Pharmacogenomics J. 2021 Apr;21(2):233-242. doi: 10.1038/s41397-020-00203-7. Epub 2021 Jan 18. Pharmacogenomics J. 2021. PMID: 33462346
Precision Medicine in Lymphoma by Innovative Instrumental Platforms.
Di Paolo A, Arrigoni E, Luci G, Cucchiara F, Danesi R, Galimberti S. Di Paolo A, et al. Among authors: cucchiara f. Front Oncol. 2019 Dec 17;9:1417. doi: 10.3389/fonc.2019.01417. eCollection 2019. Front Oncol. 2019. PMID: 31921674 Free PMC article. Review.
erbB in NSCLC as a molecular target: current evidences and future directions.
Del Re M, Cucchiara F, Petrini I, Fogli S, Passaro A, Crucitta S, Attili I, De Marinis F, Chella A, Danesi R. Del Re M, et al. Among authors: cucchiara f. ESMO Open. 2020 Aug;5(4):e000724. doi: 10.1136/esmoopen-2020-000724. ESMO Open. 2020. PMID: 32820012 Free PMC article. Review.
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone.
Crucitta S, Del Re M, Paolieri F, Bloise F, Sbrana A, Sammarco E, Mercinelli C, Cucchiara F, Fontanelli L, Galli L, Danesi R. Crucitta S, et al. Among authors: cucchiara f. Cancer Chemother Pharmacol. 2020 Oct;86(4):527-533. doi: 10.1007/s00280-020-04133-w. Epub 2020 Sep 18. Cancer Chemother Pharmacol. 2020. PMID: 32945940
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients.
Del Re M, Crucitta S, Lorenzini G, De Angelis C, Diodati L, Cavallero D, Bargagna I, Cinacchi P, Fratini B, Salvadori B, Ghilli M, Roncella M, Fontana A, Danesi R, Cucchiara F. Del Re M, et al. Among authors: cucchiara f. Pharmacol Res. 2021 Jan;163:105241. doi: 10.1016/j.phrs.2020.105241. Epub 2020 Oct 10. Pharmacol Res. 2021. PMID: 33049397
Understanding EGFR heterogeneity in lung cancer.
Passaro A, Malapelle U, Del Re M, Attili I, Russo A, Guerini-Rocco E, Fumagalli C, Pisapia P, Pepe F, De Luca C, Cucchiara F, Troncone G, Danesi R, Spaggiari L, De Marinis F, Rolfo C. Passaro A, et al. Among authors: cucchiara f. ESMO Open. 2020 Oct;5(5):e000919. doi: 10.1136/esmoopen-2020-000919. ESMO Open. 2020. PMID: 33067323 Free PMC article. Review.
Blood-based PD-L1 analysis in tumor-derived extracellular vesicles: Applications for optimal use of anti-PD-1/PD-L1 axis inhibitors.
Del Re M, van Schaik RHN, Fogli S, Mathijssen RHJ, Cucchiara F, Capuano A, Scavone C, Jenster GW, Danesi R. Del Re M, et al. Among authors: cucchiara f. Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188463. doi: 10.1016/j.bbcan.2020.188463. Epub 2020 Nov 1. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33137405 Review.
40 results